Sectors
OCUL
Ocular Therapeutix, Inc.
9.09
4 x 9.08
1 x 9.09
bid
ask
-
0.10
1.14%
10:16 AM
timesize
| Ytd | -25.16% | |
| 1y | -25.59% |
9.04
day range
9.21
6.23
52 week range
16.44
| Open | 9.19 | Prev Close | 9.19 | Low | 9.04 | High | 9.21 | Mkt Cap | 1.99B |
| Vol | 216.12K | Avg Vol | 2.62M | EPS | -1.42 | P/E | -6.40 | Forward P/E | -6.32 |
| Beta | 0.94 | Short Ratio | 8.75 | Inst. Own | 96.46% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 9.13 | 200-d Avg | 10.02 | 1yr Est | 27.09 |
OCUL News
globenewswire.com
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BEDFORD, Mass., Aug. 07, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular” o
seekingalpha.com
Ocular Therapeutix: AXPAXLI Can Turn Retina Capacity Into A Commercial Moat
Ocular Therapeutix (OCUL) is positioned for a potential 2027 launch of AXPAXLI, with a de-risked reg
zacks.com
Ocular Therapeutix (OCUL) Reports Q2 Loss, Beats Revenue Estimates
Ocular Therapeutix (OCUL) came out with a quarterly loss of $0.35 per share versus the Zacks Consens
globenewswire.com
Ocular Therapeutix™ Reports Second Quarter 2026 Financial Results and Business Highlights
Ocular's AXPAXLI TM wet AMD NDA submission on track for Q4 2026 following positive Type C Meeting wi
benzinga.com
Earnings Scheduled For May 5, 2026
benzinga.com
Penumbra, ImmunityBio, Calix, Matson And Other Big Stocks Moving Higher On Thursday
benzinga.com
Earnings Scheduled For November 4, 2025
benzinga.com
Earnings Scheduled For August 5, 2025
benzinga.com
Earnings Scheduled For May 5, 2025
benzinga.com
Earnings Scheduled For November 7, 2023
Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings
benzinga.com
12 Biggest Mid-Day Losers For Monday
12 Biggest Mid-Day Losers For Monday
benzinga.com
Earnings Scheduled For May 15, 2015
Earnings Scheduled For May 15, 2015
benzinga.com
IPO Outlook: Inotek's Vision For The Future
IPO Outlook: Inotek's Vision For The Future